Log in to save to my catalogue

A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T ly...

A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T ly...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777913426

A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis

About this item

Full title

A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis

Publisher

Kidlington: Elsevier Limited

Journal title

Annals of the rheumatic diseases, 2014-03, Vol.73 (Suppl 1), p.A71

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Limited

More information

Scope and Contents

Contents

Background and Objectives We previously demonstrated that the purified microbial polysaccharide Galactoxylomannan (GalXM) from the opportunistic fungus Cryptococcus neoformans is able to impair T-cell proliferation and to induce T lymphocyte apoptosis following the interaction with CD45 in normal subjects. Since T lymphocytes are crucially involved...

Alternative Titles

Full title

A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1777913426

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777913426

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2013-205124.162

How to access this item